1) Ho:LuLF crystal
Ho∶LuLF晶体
2) Ho co-doped YVO4 crystal
Ho双掺YVO4晶体
3) HO-1/CO
HO-1/CO体系
1.
Objective:The effect to pneumocardial disease of the routine treatment which consists of modern medicine and the treatment of Chinese medicine of huoxue-lishui-qingfei,and,the contribution of the system of heme oxygenase/carbon monoxide(HO-1/CO).
结论在西医常规治疗基础上加用活血行水清肺中药对肺心病急性发作期有明显疗效,且对血气分析、血浆CO含量有明显改善作用;患者血浆CO含量与缺氧程度呈正相关,提示HO-1/CO体系在肺心病急性发作及缓解过程中起重要作用。
4) NiAl-Cr(Mo)-Ho-Hf eutectic alloy
NiAl-Cr(Mo)-Ho-Hf共晶合金
5) ho-group
ho-群
1.
In this paper we generalized the methods of [l][2] to construct the free hl-groupsgenerated by an ho-group in any sub-product class W of half l-groups.
构造了在任意一个半格群的子积类中由一个ho-群所生成的自由半格群。
6) Heme oxygenase-1
HO-1
1.
Objective To investigate the effects of expression of heme oxygenase-1 mRNA and its protein in the transplanted rat on ischemia and reperfusion injury.
目的探讨血红素氧合酶-1(HO-1)在大鼠同种异体移植肝脏中的表达及其对供肝缺血再灌注损伤的防护作用。
2.
Objective To investigate the neuroprotective effect of heme oxygenase-1 induced by hemin on the rat brain after ischemia-reperfusion.
方法成功建立成年W istar大鼠全脑缺血再灌注模型后,于全脑缺血10 m in再灌注24、48、72 h 3个时相点观察缺血再灌注对大鼠脑组织血红素加氧酶-1(hem e oxygenase-1,HO-1)蛋白表达及皮质神经元的作用及变化规律;并于模型成功建立后5 m in,1、2 d侧脑室内注射25mg/kg的血晶素,观察血晶素对缺血再灌注大鼠脑HO-1蛋白表达及皮质神经元的影响。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条